In addition, a correlation was detected between the mRNA expressions and serum levels of OX40 and the EDSS of MS patients, but not in NMO subjects, hence the proposition that OX40-OX40L signaling is involved in the pathogenesis of MS, not NMO. The gene discussed is TNFRSF4; the disease is myeloid sarcoma.